| Literature DB >> 35126750 |
Fabian Standl1, Bernd Kowall1, Anna Katharina Frost1, Bastian Brune2,3, Marcus Brinkmann4, Marcel Dudda2,3, Florian Oesterling5, Philipp Jansen6, Karl-Heinz Jöckel1, Andreas Stang1,7.
Abstract
Current European research estimates the number of undetected active SARS-CoV-2 infections (dark figure) to be two- to 130-fold the number of detected cases. We revisited the population-wide antigen tests in Slovakia and South Tyrol and calculated the dark figure of active cases in the vulnerable populations and the number of undetected active cases per detected active case at the time of the population-wide tests. Our analysis follows three steps: using the sensitivities and specificities of the used antigen tests, we first calculated the number of test-positive individuals and the proportion of actual positives in those who participated in the antigen tests. We then calculated the dark figure in the total population of Slovakia and South Tyrol, respectively. Finally, we calculated the ratio of the dark figure in the vulnerable population to the number of newly detected infections through PCR tests. Per one positive PCR result, another 0.15 to 0.71 cases must be added in South Tyrol and 0.01 to 1.25 cases in Slovakia. The dark figure was in both countries lower than assumed by earlier studies. ©2021 JOURNAL of MEDICINE and LIFE.Entities:
Keywords: SARS-CoV-2; antigen tests; corona; dark figure; pandemic
Mesh:
Year: 2021 PMID: 35126750 PMCID: PMC8811667 DOI: 10.25122/jml-2021-0243
Source DB: PubMed Journal: J Med Life ISSN: 1844-122X
Diagnostic criteria of the antigen tests and estimation of the number of undetected active cases (dark figure) per detected active case.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
|
| 82.50 | 98.95 | 9.92*10-5 | 536 | 0.01 |
| 82.50 | 99.60 | 8.02*10-3 | 43,326 | 1.11 | ||
| 73.70 | 98.95 | 1.11*10-4 | 601 | 0.02 | ||
| 73.70 | 99.60 | 8.98*10-3 | 48,528 | 1.25 | ||
| 88.80 | 98.95 | 9.21*10-5 | 498 | 0.01 | ||
| 88.80 | 99.60 | 7.44*10-3 | 40,238 | 1.04 | ||
|
| 87.80 | 99.30 | 4.11*10-3 | 22,222 | 0.57 | |
| 87.80 | 99.60 | 8.02*10-3 | 43,326 | 1.11 | ||
| 74.50 | 99.30 | 4.85*10-3 | 26,226 | 0.67 | ||
| 74.50 | 99.60 | 8.88*10-3 | 48,004 | 1.24 | ||
| 94.70 | 99.30 | 3.81*10-3 | 20,591 | 0.53 | ||
| 94.70 | 99.60 | 6.98*10-3 | 37,721 | 0.97 | ||
|
|
| 79.60 | 100.00 | 1.26*10-2 | 6,545 | 0.60 |
| 67.10 | 100.00 | 1.49*10-2 | 7,764 | 0.71 | ||
| 98.30 | 100.00 | 1.02*10-2 | 5,300 | 0.49 | ||
|
| 87.80 | 99.30 | 3.44*10-3 | 1,791 | 0.16 | |
| 87.80 | 99.60 | 7.30*10-3 | 3,805 | 0.35 | ||
| 74.50 | 99.30 | 4.05*10-3 | 2,114 | 0.19 | ||
| 74.50 | 99.60 | 8.09*10-3 | 4,216 | 0.39 | ||
| 94.70 | 99.30 | 3.18*10-3 | 1,660 | 0.15 | ||
| 94.70 | 99.60 | 6.35*10-3 | 3,313 | 0.30 |
To manually calculate the table from left to right for each line, please use the respective share of sensitivity and specificity. The amount of test-positive TP individuals was 38,359 in Slovakia and 3,615 in South Tyrol. The antigen tested population size NT was 3,625,332 in Slovakia and 361,781 in South Tyrol. Subsequently, the adjusted share of positive antigen tests in the tested population P can be calculated using the formula below. To calculate the dark figure of active cases in the vulnerable population D, please use the following specifications and formula below: P as calculated in the previous step, the total population size N 5,460,550 was for Slovakia and 536,667 for South Tyrol. The number of people for N90, persons who had a positive PCR result in the 90 days before the antigen tests – and were therefore excluded from the antigen tests by the respective health authorities – was 55,327 in Slovakia and 15,293 in South Tyrol. To calculate the undetected active cases per detected active case D, from the previous step, must be divided by the sum of PCR positive cases in the 20 days before the antigen test. For Slovakia, the corresponding sum is 38,867, and for South Tyrol, 10,917. Please note: P becomes negative when the estimated number of false-positive individuals is higher than the number of test-positive persons. We excluded negative values from further analysis and reporting, as negative values would indicate that the tests would result in more false-positive than correct positive results.